MENU
+Compare
CNTX
Stock ticker: NASDAQ
AS OF
May 8, 04:59 PM (EDT)
Price
$0.77
Change
-$0.00 (-0.00%)
Capitalization
69.34M

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNTX with price predictions
May 07, 2025

CNTX's Stochastic Oscillator sits in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for CNTX crossed bullishly above the 50-day moving average on April 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTX advanced for three days, in of 154 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 87 cases where CNTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CNTX moved out of overbought territory on April 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNTX as a result. In of 59 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNTX turned negative on May 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

CNTX moved below its 50-day moving average on May 07, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNTX broke above its upper Bollinger Band on April 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.760) is normal, around the industry mean (14.238). P/E Ratio (0.000) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.967).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 16.00% to -5 cents per share on August 06

Context Therapeutics CNTX Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.03
The last earnings report on May 07 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 66.94K shares outstanding, the current market capitalization sits at 69.34M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNE15.990.28
+1.78%
GENIE ENERGY Ltd
LIN449.662.61
+0.58%
Linde plc
MSA155.800.28
+0.18%
Mine Safety
ARWR13.06-0.02
-0.15%
Arrowhead Pharmaceuticals
QXO13.34-0.05
-0.37%
QXO Inc

CNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with OCUL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-4.28%
OCUL - CNTX
34%
Loosely correlated
-1.74%
ELVN - CNTX
31%
Poorly correlated
-7.21%
FATE - CNTX
30%
Poorly correlated
+4.41%
OBIO - CNTX
30%
Poorly correlated
+1.65%
SLN - CNTX
30%
Poorly correlated
-1.33%
More